HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

N Sato Selected Research

sulfoquinovosylacylglycerol

1/2005Treatment with beta-SQAG9 prevents rat hepatic ischemia-reperfusion injury.
9/2004Synthetic sulfonolipids deduced from sulfonoquinovosyl diacylglycerols of sea urchin reduces hepatic ischemia-reperfusion injury in rats.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


N Sato Research Topics

Disease

56Neoplasms (Cancer)
01/2020 - 01/2000
15Pancreatic Neoplasms (Pancreatic Cancer)
11/2007 - 01/2000
13Infections
05/2005 - 01/2000
9Breast Neoplasms (Breast Cancer)
06/2017 - 02/2000
9Neoplasm Metastasis (Metastasis)
12/2007 - 01/2000
7Stomach Neoplasms (Stomach Cancer)
11/2005 - 01/2000
7Carcinoma (Carcinomatosis)
09/2001 - 06/2000
6Fibrosis (Cirrhosis)
01/2020 - 03/2000
6Inflammation (Inflammations)
11/2012 - 01/2000
6Body Weight (Weight, Body)
01/2010 - 04/2000
6Prostatic Neoplasms (Prostate Cancer)
01/2006 - 01/2000
6Wounds and Injuries (Trauma)
01/2005 - 01/2000
5Alzheimer Disease (Alzheimer's Disease)
04/2008 - 05/2000
5Ischemia
04/2006 - 03/2000
5Hypertension (High Blood Pressure)
01/2001 - 05/2000
4Pain (Aches)
03/2015 - 01/2001
4Lung Neoplasms (Lung Cancer)
12/2013 - 01/2000
4Hypersensitivity (Allergy)
02/2011 - 01/2004
4Essential Hypertension
05/2010 - 05/2000
4Esophageal Neoplasms (Esophageal Cancer)
01/2005 - 01/2000
4Reperfusion Injury
01/2005 - 09/2000
4Adenocarcinoma
08/2003 - 01/2000
4Pulmonary Sarcoidosis
04/2003 - 06/2000
4Sarcoidosis (Schaumann Disease)
04/2003 - 06/2000
4Pulmonary Hypertension
04/2002 - 12/2000
4Carcinogenesis
11/2001 - 06/2000
4Pancreatitis
09/2001 - 01/2000
4Colonic Neoplasms (Colon Cancer)
07/2001 - 06/2000
4Ocular Paraneoplastic Syndromes
03/2001 - 04/2000
3Melanoma (Melanoma, Malignant)
01/2020 - 01/2000
3Sepsis (Septicemia)
01/2011 - 10/2001
3Colorectal Neoplasms (Colorectal Cancer)
01/2006 - 06/2001
3Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
08/2004 - 01/2000
3Leukemia
07/2004 - 03/2000
3Abscess
01/2003 - 01/2000
3Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
04/2002 - 05/2000
3Squamous Cell Carcinoma (Epidermoid Carcinoma)
11/2001 - 01/2000
2Stomach Ulcer (Gastric Ulcer)
12/2013 - 01/2000
2Lupus Nephritis
11/2011 - 02/2010
2Acute Lung Injury
01/2011 - 05/2000
2Septic Shock (Toxic Shock Syndrome)
01/2011 - 06/2000
2Hypoglycemia (Reactive Hypoglycemia)
01/2011 - 02/2010
2Proteinuria
02/2010 - 03/2008
2Rare Diseases (Rare Disease)
02/2010 - 12/2000
2Systemic Lupus Erythematosus (Libman-Sacks Disease)
02/2010 - 12/2000
2Insulin Resistance
02/2010 - 03/2000

Drug/Important Bio-Agent (IBA)

12Proteins (Proteins, Gene)FDA Link
07/2011 - 01/2000
10Messenger RNA (mRNA)IBA
01/2010 - 02/2000
10CytokinesIBA
09/2006 - 01/2000
9AntigensIBA
06/2013 - 01/2000
8AntibodiesIBA
02/2010 - 01/2000
8DNA (Deoxyribonucleic Acid)IBA
04/2008 - 03/2000
7Pharmaceutical PreparationsIBA
12/2013 - 01/2000
6Amoxicillin (Wymox)FDA LinkGeneric
04/2005 - 01/2000
5Biomarkers (Surrogate Marker)IBA
01/2018 - 04/2003
5Biological ProductsIBA
06/2013 - 02/2001
5Therapeutic UsesIBA
02/2012 - 06/2000
5Proton Pump InhibitorsIBA
02/2008 - 01/2000
5Complementary DNA (cDNA)IBA
12/2003 - 03/2000
5Clarithromycin (Biaxin)FDA LinkGeneric
06/2003 - 01/2000
4Nitric Oxide (Nitrogen Monoxide)FDA Link
05/2009 - 12/2000
4Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
04/2008 - 01/2000
4Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
05/2007 - 01/2000
4Prostate-Specific Antigen (Semenogelase)IBA
01/2002 - 01/2001
3EpitopesIBA
04/2010 - 01/2000
3Urea (Carbamide)FDA LinkGeneric
03/2008 - 01/2000
3Arginine (L-Arginine)FDA Link
04/2006 - 03/2001
3A-Form DNA (A-DNA)IBA
11/2005 - 06/2003
3Etoposide (VP 16)FDA LinkGeneric
08/2004 - 06/2000
3GadoliniumIBA
09/2003 - 04/2000
3Protein Isoforms (Isoforms)IBA
06/2003 - 11/2001
3Interleukin-12 (IL 12)IBA
04/2003 - 06/2000
3Dendrimers (Dendrons)IBA
11/2001 - 07/2001
3AvidinIBA
11/2001 - 06/2000
3Gadolinium DTPA (Magnevist)FDA Link
09/2001 - 07/2001
3Ethanol (Ethyl Alcohol)IBA
09/2001 - 03/2000
3Telomerase (Telomerase Reverse Transcriptase)IBA
06/2001 - 06/2000
3RecoverinIBA
03/2001 - 04/2000
3Retinaldehyde (Retinal)IBA
03/2001 - 04/2000
3ApolipoproteinsIBA
10/2000 - 03/2000
2Indicators and Reagents (Reagents)IBA
11/2017 - 03/2001
2Formaldehyde (Formol)FDA Link
03/2015 - 11/2007
2Cyclophosphamide (Cytoxan)FDA LinkGeneric
11/2013 - 12/2001
2Fluorouracil (Carac)FDA LinkGeneric
11/2013 - 07/2001
2LigandsIBA
11/2012 - 10/2001
2Phenobarbital (Luminal)FDA Link
07/2012 - 04/2006
2Glutamine (L-Glutamine)FDA Link
07/2012 - 04/2006
2LipopolysaccharidesIBA
02/2011 - 05/2007
2Glucose (Dextrose)FDA LinkGeneric
01/2011 - 02/2010
2Insulin (Novolin)FDA Link
01/2011 - 10/2006
2Oxygen (Dioxygen)IBA
01/2011 - 07/2002
2Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)IBA
05/2009 - 04/2006

Therapy/Procedure

25Therapeutics
06/2017 - 01/2000
7Drug Therapy (Chemotherapy)
06/2017 - 01/2000
6Transplantation
01/2005 - 05/2000
3Neoadjuvant Therapy
05/2014 - 07/2012
3Radiotherapy
12/2007 - 01/2000
3Combined Modality Therapy
01/2000 - 01/2000
2Immunotherapy
06/2013 - 07/2001
2Aftercare (After-Treatment)
10/2012 - 03/2001